Geron Corp (GERN) Tops Q3 EPS by 2c

Go back to Geron Corp (GERN) Tops Q3 EPS by 2c

Geron Corporation Reports Third Quarter 2018 Financial Results and Recent Company Events

November 1, 2018 4:05 PM EDT

Imetelstat program transition proceeding, including plans to initiate Phase 3 portion of IMerge Abstracts for IMbark and IMerge accepted for oral presentation at American Society of Hematology Meeting (ASH) in December Conference call scheduled for 4:30 p.m. ET today

MENLO PARK, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced recent company events and reported financial results for the three and nine months ended September 30, 2018. The Company ended the third quarter of 2018 with $184.8 million in cash and marketable securities and expects to utilize these financial resources to advance... More